PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $8,000 | -96.5% | 2,758 | -95.9% | 0.00% | -95.2% |
| Q3 2017 | $228,000 | +240.3% | 67,233 | +146.3% | 0.02% | +250.0% |
| Q2 2017 | $67,000 | -72.4% | 27,300 | -74.5% | 0.01% | -73.9% |
| Q1 2017 | $243,000 | +56.8% | 107,100 | +46.3% | 0.02% | +21.1% |
| Q4 2016 | $155,000 | +18.3% | 73,200 | +87.1% | 0.02% | +35.7% |
| Q3 2016 | $131,000 | +39.4% | 39,129 | +31.3% | 0.01% | +7.7% |
| Q2 2016 | $94,000 | -45.7% | 29,800 | -13.5% | 0.01% | -48.0% |
| Q3 2015 | $173,000 | +440.6% | 34,458 | +665.7% | 0.02% | +525.0% |
| Q1 2015 | $32,000 | -8.6% | 4,500 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $35,000 | -73.9% | 4,500 | -67.4% | 0.01% | -72.2% |
| Q2 2014 | $134,000 | +135.1% | 13,800 | +102.9% | 0.02% | +125.0% |
| Q1 2014 | $57,000 | -27.8% | 6,800 | -27.0% | 0.01% | -38.5% |
| Q4 2013 | $79,000 | +139.4% | 9,320 | +121.9% | 0.01% | +160.0% |
| Q3 2013 | $33,000 | – | 4,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |